Nanjing Sinolife United Company Limited (HKG:3332)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Manufacture & Sale of Nutritional Supplements & Packaged Health Food Products	772.93M	747.90M	563.96M	274.85M	252.33M
Total	772.93M	747.90M	563.96M	274.85M	252.33M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Mainland China	649.30M	623.54M	432.39M	172.67M	149.95M
New Zealand	105.41M	100.10M	113.71M	85.89M	82.73M
Australia	1.49M	8.41M	4.70M	3.61M	5.23M
Other Countries	11.25M	10.15M	8.19M	7.84M	10.61M
Vietnam	5.49M	5.70M	4.97M	4.84M	3.82M
Total	772.93M	747.90M	563.96M	274.85M	252.33M

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 11, 2026

Data Sources Report a data error